Genzyme plant goes idle for sanitizing

Genzyme is temporarily halting drug production at its Allston, MA, plant due to viral contamination in a bioreactor. Though the virus is not known to be a threat to humans, production will cease for the facility to be sanitized. Genzyme expects the plant to be operational by the end of July. Report

Suggested Articles

It’s final: England won’t be covering AZ’s quick-selling Tagrisso in previously untreated non-small cell lung cancer patients with EGFR mutatations.

Top J&J meds have managed to hang onto market share in the face of new generics and biosims, but the drugmaker expects the pain to continue in 2020.

Lonza’s search for a new CEO is expected to be wrapped up this year as the CDMO homes in on a list of veterans from outside the company.